We are live on
!
Find out more
BFC
Blue Fin Capital Portfolio holdings
AUM
$692M
1-Year Est. Return
27.29%
This Fund
S&P 500
This Quarter
Est. Return
+5.04%
1 Year Est. Return
+27.29%
3 Year Est. Return
+125.18%
5 Year Est. Return
+168.38%
10 Year Est. Return
+590.83%
AUM
$125M
AUM Growth
+$11.3M
(+9.9%)
Cap. Flow
+$5.85M
Cap. Flow
% of AUM
4.69%
Top 10 Holdings %
Top 10 Hldgs %
31.83%
Holding
131
New
12
Increased
58
Reduced
39
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco Senior Loan ETF
BKLN
|
+$503K |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$356K |
| 3 |
Accenture
ACN
|
+$331K |
| 4 |
Sturm, Ruger & Co
RGR
|
+$266K |
| 5 |
Qualcomm
QCOM
|
+$247K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$224K |
| 2 |
Southern Copper
SCCO
|
+$212K |
| 3 |
Rayonier
RYN
|
+$206K |
| 4 |
iShares Core S&P Small-Cap ETF
IJR
|
+$118K |
| 5 |
iShares Russell 3000 ETF
IWV
|
+$98.9K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.56% |
| 2 | Healthcare | 11.23% |
| 3 | Financials | 10.05% |
| 4 | Energy | 9.77% |
| 5 | Consumer Staples | 9.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Coca-Cola
KO
$372B
| $1.31M | 1.05% |
30,902
+250
| +0.8% | +$10.1K |
|
27
ConocoPhillips
COP
$144B
| $1.28M | 1.03% |
14,984
+350
| +2% | +$27.3K |
|
28
Altria Group
MO
$114B
| $1.27M | 1.02% |
30,405
+1,345
| +5% | +$54.1K |
|
29
Philip Morris
PM
$291B
| $1.21M | 0.97% |
14,353
-410
| -3% | -$35.3K |
|
30
Bank of America
BAC
$440B
| $1.19M | 0.95% |
77,326
+2,165
| +3% | +$33.6K |
|
31
Procter & Gamble
PG
$345B
| $1.16M | 0.93% |
14,734
+578
| +4% | +$46.6K |
|
32
Walmart Inc
WMT
$888B
| $1.16M | 0.93% |
46,176
-105
| -0.2% | -$2.7K |
|
33
NextEra Energy
NEE
$182B
| $1.15M | 0.92% |
44,784
+3,260
| +8% | +$79.3K |
|
34
McDonald's
MCD
$191B
| $1.11M | 0.89% |
11,035
-110
| -1% | -$11.1K |
|
35
Meta Platforms (Facebook)
META
$1.5T
| $1.1M | 0.88% |
16,388
+1,545
| +10% | +$95K |
|
36
JPMorgan Chase
JPM
$950B
| $1.07M | 0.86% |
18,538
-70
| -0.4% | -$3.94K |
|
37
SLB Ltd
SLB
$75.4B
| $1.06M | 0.85% |
9,027
-75
| -0.8% | -$7.73K |
|
38
Deluxe
DLX
$1.24B
| $1.05M | 0.84% |
17,985
+2,175
| +14% | +$119K |
|
39
PepsiCo
PEP
$190B
| $1.05M | 0.84% |
11,800
-715
| -6% | -$61.7K |
|
|
RTN
40
DELISTED
Raytheon Company
RTN
| $1.03M | 0.82% |
11,145
+1,315
| +13% | +$128K |
|
41
Southern Company
SO
$107B
| $992K | 0.8% |
21,855
+160
| +0.7% | +$7.07K |
|
|
PCL
42
DELISTED
PLUM CREEK TIMBER CO (REIT)
PCL
| $991K | 0.79% |
21,968
| – | – |
|
43
Wells Fargo
WFC
$267B
| $990K | 0.79% |
18,844
+1,020
| +6% | +$51.3K |
|
44
Yum! Brands
YUM
$40.3B
| $961K | 0.77% |
16,456
+745
| +5% | +$41.4K |
|
45
AbbVie
ABBV
$431B
| $959K | 0.77% |
16,985
-255
| -1% | -$13.4K |
|
46
Lockheed Martin
LMT
$136B
| $940K | 0.75% |
5,850
+950
| +19% | +$154K |
|
|
LO
47
DELISTED
LORILLARD INC COM STK
LO
| $912K | 0.73% |
14,965
+775
| +5% | +$45.1K |
|
48
Eli Lilly
LLY
$995B
| $892K | 0.71% |
14,340
+100
| +0.7% | +$5.97K |
|
49
Blackrock
BLK
$175B
| $878K | 0.7% |
2,748
+312
| +13% | +$95.6K |
|
50
BP
BP
$109B
| $867K | 0.69% |
20,083
-617
| -3% | -$25.4K |
|
Similar funds
CL
CPA
NMC
SSA
WC
CGIC
LCP
SAM
Blue Fin Capital's Q2 2014 Portfolio in Review
As of Q2 2014, Blue Fin Capital held 131 positions worth $125M, up 9.9% from $113M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Blue Fin Capital deployed $5.85M of net new capital in Q2 2014, opening 12 new positions and adding to 58 existing holdings. Its largest new stake was Accenture: 4,125 shares worth $333K.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 9.9% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Rayonier, an estimated $206K trimmed.
- Blue Fin Capital's largest Q2 2014 buy was Accenture: 4,125 shares worth $333K.
- Blue Fin Capital added most to Invesco Senior Loan ETF in Q2 2014, an estimated $503K increase.
- Blue Fin Capital's biggest Q2 2014 reduction was Rayonier, cutting an estimated $206K.
- Blue Fin Capital fully exited Boston Scientific in Q2 2014, selling an estimated $224K.
- Blue Fin Capital's ten largest holdings make up 32% of its $125M portfolio in Q2 2014.
- Blue Fin Capital opened 12 new positions and closed 2 in Q2 2014.
- Blue Fin Capital's portfolio value rose 9.9% quarter-over-quarter to $125M.
Based on Blue Fin Capital's 13F filing for Q2 2014, filed 29 Jul 2014.